Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,489
datasets available to search
ShareScore release 0.9.0
Dataset results
2,489 results for “Sars-CoV-2”
Study on Safety and Clinical Efficacy of AZVUDINE in Initial Stage COVID-19 Patients (SARS-CoV-2 Infected)
ClinicalTrials.gov study NCT05033145. IPD Sharing: NO. Countries: 1. Publications: 1.
Clinical Trial For SARS-CoV-2 Vaccine (COVID-19)
ClinicalTrials.gov study NCT04582344. IPD Sharing: NO. Countries: 1. Publications: 4.
To Evaluate the Immunogenicity and Safety of Sequential Booster Immunization of Recombinant Novel Coronavirus Vaccine (CHO Cells) for SARS-CoV-2
ClinicalTrials.gov study NCT05895110. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Immunogenicity of Prime-boost Vaccination of SARS-CoV-2 in Patients With Cancer
ClinicalTrials.gov study NCT05273541. IPD Sharing: Not stated. Countries: 1. Publications: 6.
Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults
ClinicalTrials.gov study NCT04798001. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2
ClinicalTrials.gov study NCT04611802. IPD Sharing: NO. Countries: 3. Publications: 7.
Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System
ClinicalTrials.gov study NCT04743388. IPD Sharing: NO. Countries: 1. Publications: 4.
Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19
ClinicalTrials.gov study NCT04373148. IPD Sharing: NO. Countries: 1. Publications: 1.
Heterologous Boost Immunization with an Aerosolised Ad5-nCoV After Two-dose Priming with an Inactivated SARS-CoV-2 Vaccine
ClinicalTrials.gov study NCT05204589. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Immune Response of Adjuvanted SARS-CoV-2 (COVID-19) Beta Variant RBD Recombinant Protein (DoCo-Pro-RBD-1 + MF59®) and mRNA (MIPSCo-mRNA-RBD-1) Vaccines in Healthy Adults
ClinicalTrials.gov study NCT05272605. IPD Sharing: NO. Countries: 1. Publications: 1.
A FIRST IN HUMAN TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF SARS-CoV-2 UQSC2 VACCINE IN HEALTHY ADULTS.
ClinicalTrials.gov study NCT05775887. IPD Sharing: NO. Countries: 1. Publications: 1.
Prevalence of Antibodies Against SARS-CoV-2 Virus That Causes COVID-19 in Tübingen Children
ClinicalTrials.gov study NCT04581889. IPD Sharing: NO. Countries: 1. Publications: 9.
Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection
ClinicalTrials.gov study NCT04385095. IPD Sharing: NO. Countries: 1. Publications: 2.
SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 Patients
ClinicalTrials.gov study NCT04521309. IPD Sharing: NO. Countries: 1. Publications: 13.
Relationship Between Oral Findings and Salivary Factors in Sars-Cov-2 Patients
ClinicalTrials.gov study NCT05476848. IPD Sharing: NO. Countries: 1. Publications: 3.
Epileptic Seizure in Epilepsy Patients After SARS-CoV-2 Vaccination
ClinicalTrials.gov study NCT05341713. IPD Sharing: UNDECIDED. Countries: 1. Publications: 5.
Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine
ClinicalTrials.gov study NCT06402318. IPD Sharing: NO. Countries: 1. Publications: 4.
Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia
ClinicalTrials.gov study NCT04332913. IPD Sharing: UNDECIDED. Countries: 1. Publications: 14.
SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study
ClinicalTrials.gov study NCT04494776. IPD Sharing: NO. Countries: 1. Publications: 7.
SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease
ClinicalTrials.gov study NCT04896606. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.